Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
Sponsor: Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Summary
This is a Phase 2a multicenter, randomized, double-blind, placebo-controlled clinical trial studying the efficacy, safety, and tolerability of orally administered TERN-601 in adults with overweight or obesity.
Official title: A Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of TERN-601 in Adults With Overweight or Obesity
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
167
Start Date
2025-03-07
Completion Date
2025-09-19
Last Updated
2026-08-10
Healthy Volunteers
No
Conditions
Interventions
TERN-601
Investigational drug
Matching Placebo
Matching placebo
Locations (17)
FALCON Research Site
Birmingham, Alabama, United States
FALCON Research Site
Homewood, Alabama, United States
FALCON Research Site
Tucson, Arizona, United States
FALCON Research Site
Spring Valley, California, United States
FALCON Research Site
Port Orange, Florida, United States
FALCON Research Site
Louisville, Kentucky, United States
FALCON Research Site
Marrero, Louisiana, United States
FALCON Research Site
Boston, Massachusetts, United States
FALCON Research Site
Rochester, Minnesota, United States
FALCON Research Site
City of Saint Peters, Missouri, United States
FALCON Research Site
Beachwood, Ohio, United States
FALCON Research Site
Medford, Oregon, United States
FALCON Research Site
Dallas, Texas, United States
FALCON Research Site
Houston, Texas, United States
FALCON Research Site
San Antonio, Texas, United States
FALCON Research Site
St. George, Utah, United States
FALCON Research Site
Arlington, Virginia, United States